These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 20571421)

  • 1. Youth-specific considerations in the development of preexposure prophylaxis, microbicide, and vaccine research trials.
    Rudy BJ; Kapogiannis BG; Lally MA; Gray GE; Bekker LG; Krogstad P; McGowan I
    J Acquir Immune Defic Syndr; 2010 Jul; 54 Suppl 1(Suppl 1):S31-42. PubMed ID: 20571421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical development of microbicides for the prevention of HIV infection.
    D'Cruz OJ; Uckun FM
    Curr Pharm Des; 2004; 10(3):315-36. PubMed ID: 14754390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Superior Efficacy of a Human Immunodeficiency Virus Vaccine Combined with Antiretroviral Prevention in Simian-Human Immunodeficiency Virus-Challenged Nonhuman Primates.
    Le Grand R; Dereuddre-Bosquet N; Dispinseri S; Gosse L; Desjardins D; Shen X; Tolazzi M; Ochsenbauer C; Saidi H; Tomaras G; Prague M; Barnett SW; Thiebaut R; Cope A; Scarlatti G; Shattock RJ
    J Virol; 2016 Jun; 90(11):5315-5328. PubMed ID: 27009957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microbicide research in developing countries: have we given the ethical concerns due consideration?
    Moodley K
    BMC Med Ethics; 2007 Sep; 8():10. PubMed ID: 17877834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV research in South Africa: Advancing life.
    Gray G; Doherty T; Mohapi L; Coetzee J; Hopkins KL; Malahleha M; Lazarus E; Dietrich J; Pillay-van Wyk V; Laher F
    S Afr Med J; 2019 Dec; 109(11b):36-40. PubMed ID: 32252866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sexuality, HIV risk and potential acceptability of involving adolescent girls in microbicide research in Kisumu, Kenya.
    Montandon M; Sahin-Hodoglugil NN; Bukusi E; Agot K; Boland B; Cohen CR
    Sex Health; 2008 Dec; 5(4):339-46. PubMed ID: 19061553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methodological issues in sampling the local immune system of the female genital tract in the context of HIV prevention trials.
    Jespers V; Francis SC; van de Wijgert J; Crucitti T
    Am J Reprod Immunol; 2011 Mar; 65(3):368-76. PubMed ID: 21199064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preexposure Prophylaxis for Prevention of HIV Acquisition Among Adolescents: Clinical Considerations, 2020.
    Tanner MR; Miele P; Carter W; Valentine SS; Dunville R; Kapogiannis BG; Smith DK
    MMWR Recomm Rep; 2020 Apr; 69(3):1-12. PubMed ID: 32324724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attitudes towards new HIV biomedical prevention technologies among a cohort of HIV-negative gay men in Sydney, Australia.
    Poynten IM; Jin F; Prestage GP; Kaldor JM; Imrie J; Grulich AE
    HIV Med; 2010 Apr; 11(4):282-8. PubMed ID: 20015220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Challenges to conducting HIV preventative vaccine trials with adolescents.
    McClure CA; Gray G; Rybczyk GK; Wright PF
    J Acquir Immune Defic Syndr; 2004 Jun; 36(2):726-33. PubMed ID: 15167292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ethical issues in microbicide clinical trials for HIV prevention.
    Gangestad AK; Salata RA
    Curr HIV Res; 2012 Jan; 10(1):105-12. PubMed ID: 22264052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current State of Microbicide Development.
    Traore YL; Chen Y; Ho EA
    Clin Pharmacol Ther; 2018 Dec; 104(6):1074-1081. PubMed ID: 30107032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The epidemiology of new HIV infections and interventions to limit HIV transmission.
    Buchbinder S
    Top HIV Med; 2009; 17(2):37-43. PubMed ID: 19401606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biologic approaches to the prevention of sexual transmission of human immunodeficiency virus.
    Blocker ME; Cohen MS
    Infect Dis Clin North Am; 2000 Dec; 14(4):983-99. PubMed ID: 11144648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and Feasibility of Antiretroviral Preexposure Prophylaxis for Adolescent Men Who Have Sex With Men Aged 15 to 17 Years in the United States.
    Hosek SG; Landovitz RJ; Kapogiannis B; Siberry GK; Rudy B; Rutledge B; Liu N; Harris DR; Mulligan K; Zimet G; Mayer KH; Anderson P; Kiser JJ; Lally M; Brothers J; Bojan K; Rooney J; Wilson CM
    JAMA Pediatr; 2017 Nov; 171(11):1063-1071. PubMed ID: 28873128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acceptability of microbicidal vaginal rings and oral pre-exposure prophylaxis for HIV prevention among female sex workers in a high-prevalence US city.
    Peitzmeier SM; Tomko C; Wingo E; Sawyer A; Sherman SG; Glass N; Beyrer C; Decker MR
    AIDS Care; 2017 Nov; 29(11):1453-1457. PubMed ID: 28271718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of topical microbicides to prevent HIV-1 transmission: concepts, testing, lessons learned.
    Friend DR; Kiser PF
    Antiviral Res; 2013 Sep; 99(3):391-400. PubMed ID: 23845918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV vaccines in infants and children.
    Lambert JS
    Paediatr Drugs; 2005; 7(5):267-76. PubMed ID: 16220994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV vaccine and microbicide trials turn a corner. We still don't have an effective vaccine or microbicide for the clinic, but two major trials this year brought us closer than we've ever been.
    Abdool Karim SS
    J Watch AIDS Clin Care; 2010 Jan; 22(1):2. PubMed ID: 20617574
    [No Abstract]   [Full Text] [Related]  

  • 20. Microbicides in the prevention of HIV infection: current status and future directions.
    Nuttall J
    Drugs; 2010 Jul; 70(10):1231-43. PubMed ID: 20568831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.